Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science)
Reference56 articles.
1. Abraham J. (1994). Negotiation and accommodation in expert medical risk assessment and regulation: an institutional analysis of the benoxaprofen case. Policy Sciences, 27, 53–76.
2. Abraham J. (1995). Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. London and New York: UCL Press and St Martin's Press.
3. Abraham J. (2002a). The pharmaceutical industry as political player. The Lancet, 360, 1498–1502.
4. Abraham J. (2002b). Making regulation responsive to commercial interests: Streamlining drug industry watchdogs. British Medical Journal, 325, 1164–1169.
5. Abraham J., & Davis C. (2006). Testing times: The emergence of the Practolol disaster and its challenge to British drug regulation in the modern period. Social History of Medicine, 19, 127–147.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献